Citations (9)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
Qitian Mu, Yizhi Cheng, Weilai Xu, Yungui Wang, Zhimei Chen & Jie Jin. (2010) Acquired Robertsonian translocation is not always suggestive of poor prognosis: a case of acquired Rob(13;14) in Philadelphia chromosome-negative cells of chronic myelogenous leukemia. Leukemia & Lymphoma 51:11, pages 2141-2143.
Read now
Read now
D. M. Ross & T. P. Hughes. (2008) Current and emerging tests for the laboratory monitoring of chronic myeloid leukaemia and related disorders. Pathology 40:3, pages 231-246.
Read now
Read now
Articles from other publishers (7)
Fumi Nakamura, Honoka Arai, Yasuhito Nannya, Motoshi Ichikawa, Shiho Furuichi, Fusako Nagasawa, Wataru Takahashi, Tomoyuki Handa, Yuko Nakamura, Hiroko Tanaka, Yuka Nakamura, Ko Sasaki, Satoru Miyano, Seishi Ogawa & Kinuko Mitani. (2021) Development of Philadelphia chromosome-negative acute myeloid leukemia with IDH2 and NPM1 mutations in a patient with chronic myeloid leukemia who showed a major molecular response to tyrosine kinase inhibitor therapy. International Journal of Hematology 113:6, pages 936-940.
Crossref
Crossref
Kiyomi Morita, Junji Koya, Takashi Toya, Fumihiko Nakamura & Mineo Kurokawa. (2018) Philadelphia chromosome-negative acute promyelocytic leukemia manifesting after long-term imatinib treatment for chronic myeloid leukemia: a case report and literature review. Annals of Hematology 97:6, pages 1105-1109.
Crossref
Crossref
Xiu-Feng Yin, Jing-Han Wang, Xia Li, Meng-Xia Yu, Zhi-Xin Ma & Jie Jin. (2016) Incidence of Second Malignancies of Chronic Myeloid Leukemia During Treatment With Tyrosine Kinase Inhibitors. Clinical Lymphoma Myeloma and Leukemia 16:10, pages 577-581.
Crossref
Crossref
Timothy P Hughes, David M Ross & Junia V MeloTimoth P. Hughes, David M. Ross & Junia V. Melo. 2014. Handbook of Chronic Myeloid Leukemia. Handbook of Chronic Myeloid Leukemia
21
33
.
Kyoko Inokura, Yasushi Onishi, Kenji Shimosegawa, Yoko Okitsu, Yuna Katsuoka, Tohru Fujiwara, Noriko Fukuhara, Kenichi Ishizawa & Hideo Harigae. (2012) Philadelphia-negative acute promyelocytic leukemia in a patient with chronic myeloid leukemia in complete cytogenetic response after treatment with tyrosine kinase inhibitor. Annals of Hematology 91:11, pages 1825-1826.
Crossref
Crossref
Michael J. Groves, Mark Sales, Lee Baker, Michael Griffiths, Norman Pratt & Sudhir Tauro. (2011) Factors influencing a second myeloid malignancy in patients with Philadelphia-negative -7 or del(7q) clones during tyrosine kinase inhibitor therapy for chronic myeloid leukemia. Cancer Genetics 204:1, pages 39-44.
Crossref
Crossref
M Ditschkowski, C Haferlach, C Schulte, R Trenschel & D W Beelen. (2009) Occurrence of AML in cells of donor origin after treatment of CML in relapse with imatinib and donor stem cell boost 16 years after the original allogeneic BMT. Bone Marrow Transplantation 44:4, pages 265-266.
Crossref
Crossref